EMULSIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE, A LIPOPHILIC ACRYLIC POLYMER, A FATTY ACID ESTER AND AN ANIONIC SURFACTANT

Abstract

EMULSIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE, A LIPOPHILIC ACRYLIC POLYMER, A FATTY ACID ESTER, AND AN ANIONIC SURFACTANT. This disclosure relates to compositions including 2,4-bis-{[4-(2-ethylhexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine, at least one lipophilic acrylic polymer, at least one C12-C24 fatty acid ester of a C2-C24 polyol, and at least one carboxylic anionic surfactant or carboxylate selected from the group consisting of amino acids modified with at least one C8-C30 hydrocarbon chain and their salts, as well as processes for the manufacture and use of such compositions. Figure for abstract: none

Description

Title of the invention: EMULSIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE, A LIPOPHILIC ACRYLIC POLYMER, A FATTY ACID ESTER AND AN ANIONIC SURFACTANT FIELD OF THE INVENTION

[0001] This disclosure relates to oil-in-water (O / W) emulsion compositions (emulsions) comprising 2,4-bis-{[4-(2-ethylhexyloxy)-2-hydroxy]-phenyl]-6-(4-methoxyphenyl)-1,3,5-triazine (INCI name: bis-ethylhexyloxyphenol methoxyphenyl triazine), at least one lipophilic acrylic polymer, at least one C2_C24 fatty acid ester of a C2_C24 polyol, and at least one carboxylic anionic surfactant or carboxylate selected from the group consisting of amino acids modified with at least one C8-C30 hydrocarbon-based chain and their salts, as well as processes for manufacturing and using such compositions. DISCUSSION OF THE CONTEXT

[0002] Radiation with wavelengths between 290 nm and 400 nm allows the human epidermis to tan, while radiation with wavelengths between 290 and 320 nm, called UVB rays, hinders the development of a natural tan. Exposure is also likely to cause a detrimental alteration of the biomechanical properties of the epidermis, resulting in the appearance of wrinkles leading to premature skin aging (i.e., photoaging).

[0003] UVA rays with wavelengths between 320 and 400 nm penetrate the skin more deeply than UVB rays. UVA rays cause immediate and persistent tanning of the skin. Daily exposure to UVA rays, even for a short period, under normal conditions can damage collagen and elastin fibers, resulting in changes in the skin's microrelief, the appearance of wrinkles, and uneven pigmentation (spots, uneven skin tone).

[0004] Numerous studies show the need for effective protection against UVA and UVB to prevent sunburn, photoaging, and the like.

[0005] In order to obtain a high-protection product, it is generally necessary to combine a large number of sunscreens and / or a large quantity of UV filters to achieve high levels of filtering efficiency. However, high levels of UV filters do not lend themselves to the easy formulation of compositions with a stabilized and pleasant texture.

[0006] There remains a need in the art of improved consumer care compositions which have organic UV filters and have pleasant application properties (e.g., non-greasy feel) and UV protection properties.

[0007] Accordingly, one aspect of the present disclosure is a composition that possesses organic UV filters and has pleasant application properties (e.g., non-greasy feel) and UV protection properties. Summary of the invention

[0008] This disclosure relates to emulsion compositions comprising bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT or bemotrizinol), at least one lipophilic acrylic polymer, at least one C2-C24 fatty acid ester of a C2-C24 polyol, and at least one anionic carboxylic or carboxylate surfactant selected from the group consisting of amino acids modified with at least one C8-C30 hydrocarbon chain and their salts. Preferably, the pH of the emulsion composition is 6 or higher.

[0009] This disclosure also relates to processes for the treatment, care, protection, enhancement of appearance and / or makeup of keratinous material, including the application of compositions of this disclosure to keratinous material in sufficient quantity to treat the keratinous material, care for it, enhance its appearance and / or make it up.

[0010] This disclosure also relates to methods for manufacturing emulsion compositions comprising the combination of bis-ethylhexyloxyphenol methoxyphenyl triazine, at least one lipophilic acrylic polymer, at least one C12-C24 fatty acid ester of a C2-C24 polyol, and at least one anionic carboxylic or carboxylate surfactant selected from the group consisting of amino acids modified with at least one C8-C30 hydrocarbon chain and their salts, during the formation of the emulsions. Preferably, the pH of the emulsion composition is 6 or higher.

[0011] It must be understood that both the preceding general description and the detailed description that follows are merely illustrative and explanatory and do not limit disclosure. DETAILED DESCRIPTION OF THE INVENTION

[0012] In the following description and the claims annexed thereto, it shall be understood that the terms used have their ordinary and usual meanings in the art, unless otherwise specified.

[0013] “Approximately” as used here means to within 10% of the number indicated (for example, "approximately 10%" means from 9% to 11% and "approximately 2%" means from 1.8% to 2.2%.

[0014] “A” or “an” as used here means “at least one”

[0015] “At least one” means one or more and thus includes components in individual products as well as mixtures / combinations.

[0016] As used here, all proposed ranges are intended to include each specific point and range within the given ranges, as well as combinations of intermediate sub-ranges. Thus, a range from 1 to 5 specifically includes the integers in the range 1, 2, 3, 4 and 5, as well as sub-ranges such as 2 to 5, 3 to 5, 2 to 3, 2 to 4, 1 to 4, etc., and all fractional numbers in the range such as 1,2, 2,3, 3,4, etc., and sub-ranges including these fractional numbers such as 1.5 to 3.8, 2 to 4.3, 4.2 to 4.9, etc.

[0017] “Film-forming”, “film-forming polymer” or “film-forming agent” as used herein means a polymer or resin that is capable of leaving a film on the substrate to which it is applied, for example, after a solvent accompanying the film-forming agent has evaporated, been absorbed into the substrate and / or dissipated on it.

[0018] “Substitute” as used herein means comprising at least one substitute. Non-limiting examples of substituents include atoms, such as hydrogen or chlorine atoms, as well as functional groups, such as hydroxyl groups, ether groups, alkoxy groups, acyloxyalkyl groups, oxyalkylene groups, polyoxyalkylene groups, carboxylic acid groups, amine groups, acylamino groups, amide groups, halogen-containing groups, ester groups, thiol groups, sulfonate groups, thiosulfate groups, siloxane groups, and polysiloxane groups. The substituent(s) may further be substituted.

[0019] “Volatile”, as used herein, means having a flash point below about 115 °C.

[0020] “Non-volatile”, as used here, means having a flash point greater than approximately 115 °C.

[0021] “Polymer” as used herein means a compound that is made up of at least two monomers.

[0022] “Exempt” or “substantially exempt” or “devoid of” as used herein This means that although it is preferable for no quantity of the specific component to be present in the composition, it is possible for very small quantities of it to be present in the disclosed compositions, provided that these quantities do not materially affect at least one, preferably most, of the advantageous properties of the disclosed compositions. Thus, for example, "oil-free" means that an effective amount (i.e., greater than trace amounts) of oil(s) is omitted from the composition (i.e., about 0% by weight), while "substantially oil-free" means that one or more oils are present in quantities not exceeding 0.1% by weight, and "oil-free" means that one or more oils are present in quantities not exceeding 0.25% by weight, relative to the total weight of the composition. The same nomenclature applies to all other ingredients identified throughout the application and in this paragraph, such as, for example, UV filters and / or surfactants (the compositions in the disclosure that are "free of oxybenzone and / or octinoxate", "substantially free of oxybenzone and / or octinoxate" and "free of oxybenzone and / or octinoxate", as well as "free of surfactants", "substantially free of surfactants" and "free of surfactants" have meanings consistent with the discussion in this paragraph), even if they are not specifically mentioned for each ingredient identified in the application.The examples cited of the use of such language, such as those in this paragraph, are intended to be provided as examples, not as limitations.

[0023] “UV Filters” as used herein means approved sunscreen active agents by a government regulatory agency such as the Food and Drug Administration (FDA) in the United States or the European Commission in Europe and includes organic UV filters such as avobenzone, octocrylene, benzophenones, benzotriazoles and merocyanines, as well as mineral UV filters such as zinc oxide (SnO) and titanium dioxide (TiO2).

[0024] “Anhydrous” as used here means that the compositions of the disclosure contain less than 3% water, which means that compositions may also contain less than 2% water, and less than 1% water, as well as being "water-free", "substantially water-free" and "water-free", as defined above.

[0025] "Keratinous materials" means nails (fingernails and / or toenails), skin such as the body, face and eye area, scalp, keratinous fibers such as eyelashes, eyebrows and hair, and mucous membranes such as lips.

[0026] “Physiologically acceptable” means compatible with keratinous materials and having a pleasant color, odor, and feel, and not causing unacceptable discomfort (tingling or pulling) likely to discourage a consumer from using the composition. Preferably, the pH of the emulsion composition is 6 or higher, preferably 6.5 or higher, and preferably 7 or higher.

[0027] “UV protection efficiency” or “filtering efficiency” in the In the context of this disclosure, is evaluated from one or more of FPS, FPUVA, critical wavelength and UVA-l / UV ratio.

[0028] The "SPF" (Sun Protection Factor) measures the level of protection against erythema provided by a composition. The SPF value corresponds to the ratio between the Minimum erythematous dose (MED) measured on skin covered with the composition and the MED measured on bare skin. The term "SPF" is known in the art of sunscreens and is defined, for example, in A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum, J. Soc. Cosmet. Chem., 40, 127-133 (May / June 1989).

[0029] The evaluation of the SPF (Sun Protection Factor) can be carried out, for example, in vitro with a spectrophotometer from Labsphere (North Sutton, NH, USA). In such an evaluation, the plate is the material to which the composition under test is applied. For such an evaluation, polymethyl methacrylate (PMMA) plates can be used. An example of an acceptable protocol is currently undergoing ISO accreditation under the name ISO Committee Draft 23675.

[0030] The evaluation of the sun protection factor (SPF) can also be performed in vivo according to the ISO 24444:2019 protocol "Cosmetics — Sunscreen test methods — In vivo determination of the sun protection factor (SPF)." In addition, it can be determined in accordance with FDA protocols, as described in the document "Labeling and Effectiveness Testing; Sunscreen Drug Products for Over-the-Counter Human Use" published in the US Federal Register on 07 / 05 / 2011 (https: / / www.federalregister.gov / d / 2011-14766); 21 CFR Part 352 Subpart D § 352.72, updated and revised by the 2011 publication in the Federal Register.

[0031] The "UVA protection factor" (UPF) refers to an index characterizing the UVA protection provided by a composition. For example, the UPF index can be measured in vivo according to the "PPD" (Persistent Pigment Darkening) method of the ISO-24442:2022 protocol, measuring the skin color observed 2 to 4 hours after UVA exposure. It can also be determined according to FDA protocols, as described in 21 CFR Part 352 Subpart D § 352.72 as discussed above in relation to SPF.

[0032] UVA protection can also be assessed in vitro using the Labsphere® spectrophotometer under conditions such as those mentioned above in relation to the SPF. ISO 24443:2021 describes such an in vitro procedure.

[0033] FDA broad-spectrum test procedures, particularly "critical wavelength" test procedures, are also available in 21 CFR Part 352 Subpart D § 352.72. In addition, broad-spectrum test procedures include the determination of the UVA1 / UV ratio as described in "Sunscreen Drug Products for Over-the-Counter Human Use" published in the Federal Register https: / / www.federalregister.gov / documents / 2019 / 02 / 26 / 2019-03Q19 / sunscreen-drug-products-for-over-the-counter-human-use. In the test described in the monograph, Known as the Boots adaptation of the Diffey / Robson test method, a ratio is generated between the protection offered by the sunscreen product against UVA1 (340 to 400 nm) and the protection against total UV radiation (UVB and UVA at 290 to 400 nm) calculated from the absorbance curve. This UVA1 / UV ratio represents the product's score in the in vitro test.

[0034] According to this disclosure, the compositions in this disclosure preferably have one or more of the following properties:

[0035] The compositions have a critical wavelength as determined by FDA critical wavelength procedures of at least 370 nm;

[0036] The compositions have an FPS value of at least 15, preferably at least 30, preferably at least 50 and preferably at least 70;

[0037] The compositions have an FPUVA / FPS ratio of at least 1 / 3, and preferably of at least 2 / 5; and / or

[0038] The compositions have a UVA1 / UV ratio of 0.7 or more, preferably 0.75 or more, and preferably 0.8 or more.

[0039] “The makeup result”, as used herein, refers to the visual impact of a makeup application The position when applied to a keratinous material such as skin. The makeup result can refer to the apparent color of the product after application to a keratinous material or an optical effect such as shine, blurring of fine lines and imperfections, or a concealing effect on pores or blemishes after application of the product to the keratinous material.

[0040] "Longevity" as used herein refers to compositions where the color or other apparent properties remain the same or substantially the same as at the time of application, as seen with the naked eye, after a prolonged period or after a particular stress event such as immersion in water or rubbing. "Longevity" can be evaluated by assessing the longevity properties by any method known in the art for evaluating such properties. For example, longevity can be assessed by a test involving the application of a composition to a keratinous material such as skin and evaluating the color of the composition after a prolonged period. For example, the color of a composition can be evaluated immediately after application to a keratinous material such as skin, and these characteristics can then be re-evaluated and compared after a certain time.Furthermore, these characteristics can be evaluated against other compositions, such as commercially available ones. "Longevity" can also be assessed using in vitro methods on non-keratinous substrates such as polymethyl methacrylate (PMMA), in which properties such as color, transparency, or in vitro SPF can be evaluated before and after a period or stress factor such as immersion in [a specific solution]. water, incubation at high temperatures or the application of an abrasive technique.

[0041] “Natural” as in the expression “natural compound” means any compound derived directly from a natural substance such as a plant without having undergone chemical modification.

[0042] “Compound of natural origin” means any compound derived from a natural compound which has undergone one or more chemical modifications, for example by organic synthesis reaction, without the properties of the natural compound having been modified.

[0043] “Synthetic compound” means any compound that is neither a natural compound nor a composed of natural origin.

[0044] “Room temperature” means approximately 20 to 25 °C.

[0045] “Atmospheric pressure” means approximately 760 mmHg, i.e. approximately 105 pascals.

[0046] “UV filter” and “sunscreen agent” are used interchangeably in the present request.

[0047] “Efficiency against UV” and “UV efficiency” are used interchangeably changeable in this application.

[0048] The compositions and processes of this disclosure may include, consist of, or consist substantially of the essential elements and limitations of the disclosure described herein, together with any additional or optional ingredients, components, or limitations described herein or otherwise useful. For example, the UV (ultraviolet) absorbing system of the compositions of the disclosure may "consist substantially of bis-ethylhexyloxyphenol methoxyphenyl triazine."

[0049] For the purposes of this disclosure, the "fundamental novel property" associated with compositions, components and processes that "consist essentially of" identified ingredients or actions is "UVA protection indicated by the FPUVA / FPS and UVA1 / UV ratios".

[0050] The compositions of this disclosure may be in any form suitable for use as a personal care composition, such as a stick, paste, or cream. These compositions may be used for personal care purposes in cosmetic and / or dermatological products such as, for example, sunscreen, foundation, lip balms, lipsticks, concealers, mascaras, leave-in hair products, etc.

[0051] Reference is made herein to trade names of materials including, but not limited to, polymers and optional components. The materials are not intended to be limited to the materials described and referenced herein by a particular trade name. Equivalent materials (for example, those obtained from a different source under a different name or catalogue (reference) number) to those described herein may also be used. trademarks registered under a trade name may be substituted for them and used in the processes described and claimed herein.

[0052] Unless otherwise stated, all percentages and ratios are calculated by weight. Unless otherwise stated, all percentages are calculated on the basis of the total weight of a composition. All component or composition levels refer to the active level of that component or composition and are understood to exclude impurities, for example, residual solvents or by-products, which may be present in commercially available sources.

[0053] All US patents or patent applications disclosed herein are expressly incorporated by reference in their entirety. COMPOSITION B is-ethylhexyloxyphenol methoxyphenyl triazine

[0054] According to this disclosure, compositions comprising a UV (ultraviolet) absorbing system comprising 4-bis-{[4-(2-ethylhexyloxy)-2-hydroxy]-phenyl]-6-(4-methoxyphenyl)-1,3,5-triazine (INCI name: Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine) are proposed.

[0055] According to preferred embodiments, the UV-absorbing system comprises at least 5% by weight of bis-ethylhexyloxyphenol methoxyphenyl triazine, preferably at least 15% by weight of bis-ethylhexyloxyphenol methoxyphenyl triazine, preferably at least 20% by weight of bis-ethylhexyloxyphenol methoxyphenyl triazine, preferably at least 30% by weight of bis-ethylhexyloxyphenol methoxyphenyl triazine, preferably at least 40% by weight of bis-ethylhexyloxyphenol methoxyphenyl triazine, preferably at least 50% by weight of bis-ethylhexyloxyphenol methoxyphenyl triazine, preferably at least 70% by weight of bis-ethylhexyloxyphenol methoxyphenyl triazine, preferably at least 80% by weight of bis-ethylhexyloxyphenol methoxyphenyl triazine, and preferably at least 90% by weight of the bis-ethylhexyloxyphenol methoxyphenyl triazine, all weights being based on the total weight of the UV-absorbing system.The "UV absorbing system" contains all organic UV filters and / or all mineral UV filters present in the composition.

[0056] According to preferred embodiments, bis-ethylhexyloxyphenol methoxyphenyl triazine is present in the compositions of this disclosure in an effective UV-absorbing amount such as, for example, about 0.1% to about 10% by weight relative to the total weight of the composition, about 1% to about 10% by weight, about 2.5% to about 8% by weight, and about 4% to about 6% by weight, including all intermediate ranges and sub-ranges such as, for example, about 4.5% to about 10% by weight, and about 1% to about 8% by weight. weight, from about 1% to about 6% by weight, from about 5.5% to about 8% by weight, from about 5.7% to about 9% by weight, etc., all weights being based on the total weight of the composition. Additional organic UV filter(s)

[0057] According to preferred embodiments of this disclosure, compositions comprising a UV-absorbing system optionally further comprising at least one additional organic UV filter (in addition to bis-ethylhexyloxyphenol methoxyphenyl triazine) are proposed. Such compositions may also optionally further comprise one or more mineral UV filters such as zinc oxides, titanium oxides, cerium oxides, and mixtures thereof, if desired, although the compositions may also be "free," "substantially free," or "devoid" of mineral UV filter(s).

[0058] The additional organic UV filter(s) may be hydrophilic or lipophilic. “Hydrophilic organic UV filter” means a water-soluble organic UV filter or a water-dispersible organic UV filter (in colloidal form). “Lipophilic organic UV filter” means a UV filter that is dissolved or dispersed in colloidal form in a liquid oil phase.

[0059] Suitable organic UV filters may be selected from the following non-exhaustive list of compounds: cinnamic derivatives; anthranilates; para-aminobenzoic acid compounds; salicylic compounds; dibenzoylmethane compounds; camphor compounds; benzophenone compounds; diphenylacrylate compounds; triazine compounds; benzotriazole compounds; benzalmalonate compounds including those cited in US patent 5,624,663; benzimidazole derivatives; imidazoline compounds; bis-benzoazolyl compounds as described in patents EP669323 and US 2,463,264; the compounds methylene bis(hydroxyphenyl benzotriazole) as described in applications US 5 237 071, US 5 166 355, GB2303549, DE 197 26 184 and EP893119; the compounds benzoxazole as described in patent applications EP0832642, EP1027883, EP1300137 and DE10162844;Polymer filters and silicone filters such as those described in particular in application WO-93 / 04665; alkylstyrene-derived dimers such as those described in patent application DE19855649; 4,4-diarylbutadiene compounds such as those described in applications EP0967200, DE19746654, DE19755649, EP-A-1008586, EPI 133980 and EP133981, and mixtures thereof. Preferably, lipophilic organic UV filters are selected from salicylic compounds, dibenzoylmethane compounds, benzylidene camphor compounds; benzophenone compounds; triazine compounds other than bis-ethylhexyloxyphenol methoxyphenyl triazine; benzotriazole compounds; as well as other categories of compounds identified herein; and mixtures thereof.

[0060] Specific reference may be made to suitable salicylate compounds including homosalate (homomentyl salicylate), for example marketed under the brand name "Eusolex HMS" by Rona / EM Industries; and ethylhexyl salicylate, for example marketed under the brand name "Neo Heliopan OS" by Symrise; and glycol salicylate. Other examples of salicylate compounds include phenyl salicylate; dipropylene glycol salicylate, for example marketed under the brand name "Dipsal" by Scher; and TEA salicylate, for example marketed under the brand name "Neo Heliopan TS" by Symrise.

[0061] Examples of suitable [3,[3-diphenylacrylate compounds include octocrylene, marketed for example under the brand name "Uvinul N539" by BASF; and etocrylene, marketed for example under the trade name "Uvinul N35" by BASF.

[0062] Suitable anthranilic compounds may include menthyl anthranilates, for example marketed under the brand name "Neo Heliopan MA" by Symrise.

[0063] Examples of dibenzoylmethane compounds include Butyl methoxydiben-zoylmethane, for example marketed under the brand name "Parsol 1789" by DSM; and isopropyl dibenzoylmethane.

[0064] Suitable cinnamyl compounds include ethylhexyl methoxycinnamate, marketed for example under the brand name "Parsol MCX" by DSM; isopropyl methoxycinnamate; isopropoxy methoxycinnamate; isoamyl methoxycinnamate, marketed for example under the brand name "Neo Heliopan E 1000" by Symrise; cinoxate (2-ethoxyethyl-4-methoxycinnamate); DEA methoxycinnamate; diisopropyl methylcinnamate and glyceryl ethylhexanoate dimethoxycinnamate.

[0065] Examples of camphor compounds include benzylidenecamphor derivatives: 3-benzylidenecamphor, for example marketed under the brand name "Mexoryl SD" by Chimex; 4-methylbenzylidenecamphor, for example marketed under the brand name "Eusolex 6300" by Merck; benzylidenecamphor sulfonic acid, for example marketed under the brand name "Mexoryl SL" by Noveal; benzalconium camphor methosulfate, for example marketed under the brand name "Mexoryl SO" by Noveal; dicamphor sulfonic acid terephthalylidene, for example marketed under the brand name "Mexoryl SX" by Noveal; and polyacrylamidomethylbenzylidenecamphor, for example marketed under the brand name "Mexoryl SW" by Noveal.

[0066] Suitable benzophenone compounds include benzophenone-1 (2,4-dihydroxybenzophenone), such as that marketed under the brand name "Uvinul 400" by BASF; benzophenone-2 (tetrahydroxybenzophenone), such as that marketed under the brand name "Uvinul D50" by BASF; benzophenone-3 (2-hydroxy-4-methoxybenzophenone) or oxybenzone, such as that marketed under the brand name "Uvinul M40" by BASF; benzophenone-4 (hydroxymethoxybenzophonene sulfonic acid), such as that marketed under the brand name "Uvinul MS40" by BASF; benzophenone-5 (sodium hydroxymethoxybenzophenone sulfonate); benzophenone-6 (dihydroxy dimethoxy benzophenone), such as that marketed under the brand name "Helisorb 11" by Norquay; benzophenone-8, such as that marketed under the brand name "Spectra-Sorb UV-24" by American Cyanamid; benzophenone-9 (disodium dihydroxy dimethoxy benzophenonedisulfonate), such as that marketed under the brand name "Uvinul DS-49" by BASF; and benzophenone-12, and n-hexyl 2-(4-diethylamino-2-hydroxybenzoyl)benzoate (such as that marketed under the brand name "UVINUL A+" by BASF).

[0067] Examples of triazine compounds include diethylhexyl butamido triazone, such as that marketed under the brand name "Uvasorb HEB" by Sigma 3V; 2,4,6-tris(dineopentyl 4'-aminobenzalmalonate)-s-triazine, bis-ethylhexyloxyphenol methoxyphenyl triazine, such as that marketed under the brand name "TINOSORB S" by BASF, and ethylhexyl triazone, such as that marketed under the brand name "UVTNUL T150" by BASF.

[0068] Suitable benzotriazole compounds include phenylbenzotriazole derivatives: 2-(2H-benzotriazole-2-yl)-6-dodecyl-4-methylpheno, branched and linear; and those described in USP 5240975.

[0069] Suitable benzalmalonate compounds include dineopentyl 4'-methoxybenzalmalonate, and polyorganosiloxane comprising benzalmalonate functional groups, such as polysilicone-15, such as that marketed under the brand name "Parsol SLX" by Hoffmann-LaRoche.

[0070] Examples of benzimidazole compounds include, in particular, phenylbenzimidazole derivatives such as phenylbenzimidazole sulfonic acid, such as that marketed in particular under the brand name "Eusolex 232" by Merck, and phenyl dibenzimidazole tetrasulfonate disodium, such as that marketed under the brand name "Neo Heliopan AP" by Symrise.

[0071] Suitable imidazoline compounds include ethylhexyl dimethoxybenzylidene propionate dioxoimidazoline.

[0072] Examples of bis-benzoazolyl compounds include the compounds described in EP-669 323 and US patent no. 2 463 264.

[0073] Suitable para-aminobenzoic acid compounds include PABA (p-aminobenzoic acid), ethyl PABA, ethyl dihydroxypropyl PABA, pentyl dimethyl PABA, ethylhexyl dimethyl PABA, such as that marketed under the brand name "Escalol 507" by ISP, glyceryl PABA and PEG-25 PABA, such as that marketed under the brand name "Escalol 507" by ISP, glyceryl PABA and PEG-25 PABA, such as that com- marketed under the brand name "Uvinul P25" by BASF.

[0074] Suitable methylene bis-(hydroxyphenylbenzotriazole) compounds include 2,2'-methylenebis[6-(2H-benzotriazol-2-yl)-4-methylphenol], such as that marketed under the brand name "Mixxim BB / 200" by Fairmount Chemical, 2,2'-methylenebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol], such as that marketed in micronized aqueous dispersion form under the brand name "Tinosorb M" by BASF, or under the brand name "Mixxim BB / 100" by Fairmount Chemical, and derivatives as described in US patents Nos. 5,237,071 and 5,166,355, GB-2,303,549, DE-197,261,844 and EP-893,119, and drometrizole tri-siloxane, such as that marketed under the brand name "Silatrizole" by Rhodia Chimie or - "Mexoryl XL" by L'Oréal.

[0075] Examples of benzoxazole compounds include 2,4-bis[5-l(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl)imino-1,3,5-triazine, such as that marketed under the brand name Uvasorb K2A by Sigma 3V.

[0076] Suitable examples of protective polymers and protective silicones include the silicones described in WO 93 / 04665.

[0077] Suitable α-alkylstyrene derived dimers include the dimers described in DE-19855649.

[0078] Examples of 4,4-diarylbutadiene compounds include l,l-dicarboxy(2,2'-dimethylpropyl)-4,4-diphenylbutadiene.

[0079] According to preferred embodiments, the compositions of this disclosure further comprise at least one additional organic UV filter selected from the group consisting of avobenzone (butyl methoxydibenzoylmethane), octisalate (ethylhexyl salicylate), ensulizole (phenylbenzimidazole sulfonic acid), homosalate, octocrylene, and mixtures thereof. In such embodiments, the UV-absorbing system may "consist of" or "consist essentially of" (1) bis-ethylhexyloxyphenol methoxyphenyl triazine and (2) at least one organic UV filter selected from the group consisting of avobenzone (butyl methoxydibenzoylmethane), octisalate (ethylhexyl salicylate), ensulizole (phenylbenzimidazole sulfonic acid), homosalate, octocrylene, and mixtures thereof.

[0080] According to other preferred embodiments, however, the compositions of this disclosure are “free,” “substantially free,” or “devoid,” as defined above, of one or more additional organic UV filters selected from the group consisting of avobenzone (butyl methoxydibenzoylmethane), octisalate (ethylhexyl salicylate), ensulizole (phenylbenzimidazole sulfonic acid), homosalate, and octocrylene, preferably two or more, preferably three or more, preferably four or more, or preferably all five of these screening agents. solar panels.

[0081] According to preferred embodiments, the compositions of this disclosure are "free", "substantially free" or "devoid", as defined above, of one or more additional organic UV filters selected from the group consisting of OXYBENZONE (benzophenone-3), OCTINOXATE (ethylhexyl methoxycinnamate), ETHYLHEXYL TRIAZONE, DROMETRIZOLE TRISILOXANE, METHYLENE BIS-BENZOTRIAZOLYL TETRAMETHYLBUTYL PHENOL, DIE-THYLAMINO HYDROXYBENZOYL HEXYL BENZOATE, DIETHYLHEXYL BUTAMIDO TRIAZONE, ISOAMYL P-METHOXYCINNAMATE, POLY-SILICONE-15, 4-METHYLBENZYLIDENE CAMPHOR, PHENYL DIBENZL MIDAZOLE DISODIUM TETRASULFONATE, METHOXYPROPYLAMINO CYCLOHEXENYLIDENE ETHOXYETHYLCYANOACETATE, preferably two or more, preferably three or more, preferably four or more, etc., and preferably "free", "substantially free" or "devoid" of all these sunscreens.

[0082] According to preferred embodiments, the compositions of this disclosure are "free", "substantially free" or "devoid", as defined above, of OXYBENZONE (benzophenone-3) and / or OCTINOXATE (ethylhexyl methoxycinnamate).

[0083] Preferably, where appropriate, at least one additional organic UV filter is present in the compositions of this disclosure in an amount of at least about 1% by weight, preferably at least about 5% by weight, preferably at least about 10% by weight, preferably at least about 12.5% ​​by weight, and preferably at least about 15% by weight, the upper end of the range of additional UV filter present being preferably about 40% by weight (e.g., about 1 to 40%, about 10 to 40%, about 12.5 to 40%, etc.), preferably about 30% by weight (e.g., about 5 to 30%, about 10 to 30%, about 15 to 30%, etc.), preferably about 25% by weight (e.g., about 5 to 25%, of about 10 to 25%, of about 15 to 25%, etc.), and preferably of about 20% by weight (for example, of about 1 to 20%, of about 5 to 20%, of about 10 to 20%, etc.), all weights being based on the total weight of the composition.

[0084] According to preferred embodiments, bis-ethylhexyloxyphenol methoxyphenyl triazine and at least one additional organic UV filter, if applicable, are present in compositions of this disclosure in a weight percentage ratio of approximately 10:1 to approximately 1:10, preferably approximately 5:1 to approximately 1:5, preferably approximately 3:1 to approximately 1:3, and preferably approximately 2:1 to approximately 1:2, including all intermediate ranges and sub-ranges, such as, for example, 5:1 to 2:1, 1:2 to 5:1, 8:1 to 1.5:1, 1:1.5 to 1:8, etc., all weights being based on the weight percentage of bis-ethylhexyloxyphenol methoxyphenyl triazine and the weight percentage of additional organic UV filter present in the composition. Preferably, the compositions have a higher weight percentage of additional organic UV filter than of bis-ethylhexyloxyphenol methoxyphenyl triazine.

[0085] According to preferred embodiments, the compositions of this disclosure comprise 10% or less by weight relative to the total weight of the composition of additional UV filters (including mineral UV filters), preferably less than 7.5% by weight relative to the total weight of the composition, preferably less than 5% by weight relative to the total weight of the composition, preferably less than 3% by weight relative to the total weight of the composition, and preferably less than 1% by weight relative to the total weight of the composition.

[0086] According to preferred embodiments, the compositions of this disclosure comprise 10% or less by weight relative to the total weight of the composition of additional organic UV filters, preferably less than 7.5% by weight relative to the total weight of the composition, preferably less than 5% by weight relative to the total weight of the composition, preferably less than 3% by weight relative to the total weight of the composition, and preferably less than 1% by weight relative to the total weight of the composition.

[0087] According to preferred embodiments, the UV-absorbing system of the compositions of this disclosure may "consist of" or "consist essentially of" (1) bis-ethylhexyloxyphenol methoxyphenyl triazine and (2) optionally additional organic UV filters.

[0088] According to preferred embodiments, the present disclosure envisages omitting one or more of the specific UV filters mentioned above from the UV-absorbing system of the compositions of this disclosure. By way of example, octocrylene and / or octinoxate may be omitted from the compositions. A similar omission of one or more of the specific UV filters mentioned is thus envisaged. Lipophilic acrylic polymer

[0089] According to this disclosure, emulsion compositions comprising at least one lipophilic acrylic polymer are proposed, wherein the lipophilic acrylic polymer comprises monomer units of formulas (A) and (B):

[0090] [Chem.l]

[0091] in which: • Rb, independently in each case, is chosen from among the alkyl or alkenyl radicals, and • at least 60% by weight of the RI groups are radicals selected from stearyl and behenyl radicals, the weight percentage referring to the sum of all RI groups present in the polymer, and the weight ratio between the sum of all hydroxyethyl acrylate motifs and the sum of all acrylate motifs bearing the RI group is 1:30 to 1:1, and • the sum of the total of motifs A and B is at least 95% by weight relative to the total weight of the polymer.

[0092] Preferably, Ri consists of alkyl radicals, preferably C16-C22 alkyl radicals, and preferably stearyl radicals (Cl8) or behenyl radicals (C22).

[0093] Preferably, at least 70% by weight of the RI groups are stearyl or behenyl radicals, preferably at least 80% by weight and more preferably at least 90% by weight.

[0094] According to a preferred embodiment, all RI groups are behenyl radicals.

[0095] According to another preferred embodiment, all RI groups are stearyl radicals.

[0096] Preferably, the weight ratio between the sum of all hydroxyethyl acrylate motifs and the sum of all acrylate motifs bearing the RI group is 1:15 to 1:1, preferably 1:10 to 1:4.

[0097] Advantageously, the polymer motifs present in the polymer consist of the motifs (A) and (B) described above.

[0098] The polymer preferably has a number-average molecular weight Mn ranging from 2000 to 9000 g / mol, preferably from 5000 to 9000 g / mol. The number-average molecular weight can be measured by the gel permeation chromatography method, for example according to the method described below.

[0099] The sample is prepared by preparing a 10 mg / ml solution of the polymer in tetrahydrofuran. The sample is placed in an oven at 54 °C for 10 minutes, then in an oscillating shaker for 60 minutes to facilitate dissolution. After visual inspection, the sample appeared to be completely dissolved in the solvent.

[0100] The prepared sample is analyzed using two 300 x 7.5 mm polypore columns manufactured by Agilent Technologies, a Waters 2695 chromatographic system, a tetrahydrofuran mobile phase, and refractive index detection. The sample is filtered through a 0.45 µm nylon filter before being injected into the liquid chromatograph. The standards used for calibration are Agilent Technologies' Easi Vial narrow polystyrene (PS) standards. Polystyrene standards ranging from 2,520,000 to 162 daltons can be used for calibration.

[0101] The system is equipped with a SECcurity 1260 RL PSS detector. The polystyrene calibration curve is used to determine the average molecular weight. Recording the diagrams and determining the different molecular weights can be performed using the Win GPC Unichrom 81 program.

[0102] Preferably, the polymer has a melting point ranging from 40 °C to 70 °C, preferably from 45 °C to 67 °C. The melting point is measured by differential scanning calorimetry (DSC), for example according to methods based on ASTM E791 and ASTM D 34182, and the DSC calibration is performed in accordance with ASTM E 9672.

[0103] According to preferred embodiments, when the polymer is such that at least 60% by weight of the Ri groups are stearyl radicals, then the polymer preferably has a melting point of 40 °C to 60 °C, preferably of 45 °C to 55 °C.

[0104] According to preferred embodiments, when the polymer is such that at least 60% by weight of the RI groups are behenyl radicals, then the polymer has a melting point of 60 °C to 70 °C, preferably 63 °C to 67 °C.

[0105] The polymer of the present invention can be prepared by polymerization of a monomer having the formula below:

[0106] CH2=CH-COO-R1,

[0107] RI having the meaning described above, and 2-hydroxyethyl acrylate.

[0108] Polymerization can be carried out according to known methods, such as solution polymerization or emulsion polymerization.

[0109] Polymerization is, for example, described in US document 2007 / 0264204, the entire contents of which are incorporated herein by reference.

[0110] According to preferred embodiments, at least one lipophilic acrylic polymer is present in the compositions of this disclosure in an amount (active material) of 0.05 to 10% by weight, relative to the total weight of the composition, preferably 0.1 to 5% by weight, and preferably 0.2 to 2% by weight, including all beaches and intermediate sub-beaches.

[0111] C12-C24 fatty acid esters of a C2-C24 polyol

[0112] According to this disclosure, emulsion compositions comprising at least one C12-C24 fatty acid ester of a C2-C24 polyol are proposed. Preferably, the at least one C2-C24 fatty acid ester of a C2-C24 polyol is at least a C16-C18 fatty acid ester of glycerol.

[0113] According to preferred embodiments, the fatty acid in Ci2-C24 for at least one fatty acid ester in Ci2-C24 of a C2-C24 polyol can be a saturated or unsaturated acid such as, for example, stearic acid, oleic acid, palmitic acid, etc.

[0114] For the purposes of the present invention, the term “polyol” means any organic molecule including at least two free hydroxyl groups.

[0115] According to preferred embodiments, the polyol for at least one C12-C24 fatty acid ester of a C2-C24 polyol may be a saturated or unsaturated alkyl-type compound, with a linear, branched, or cyclic structure, bearing at least two OH groups on the alkyl group, preferably at least three OH groups. Preferably, the polyol for at least one C12-C24 fatty acid ester of a C2-C24 polyol preferably has 3 to 16 carbon atoms.

[0116] Preferably, the polyol is selected, for example, from the group consisting of ethylene glycol, pentaerythritol, trimethylolpropane, propylene glycol, 1,3-propanediol, butylene glycol, isoprene glycol, pentylene glycol, hexylene glycol, polyglycerin-3, glycerol, and mixtures thereof. Preferably, the polyol is selected from 1,3-propanediol, polyglycerin-3, glycerol, pentylene glycol, and mixtures thereof. Preferably, the polyol is glycerol.

[0117] Examples of C12-C24 fatty acid esters of glycerol include glyceryl laurate, glyceryl oleate, glyceryl stearate, glyceryl palmitate, and mixtures thereof. Commercially available products include glyceryl stearate, such as the product sold under the name Tegin MO by Evonik Goldschmidt, and glyceryl laurate, such as the product sold under the name Imwitor 3120 by Hiils, and monoglyceride stearates (INCI name: Glyceryl Stearate), for example, sold under the name Dimodan HP by Danisco, or those sold under the name Tegin 90 by Evonik Goldschmidt.

[0118] Preferably, the C12-C24 fatty acid ester of glycerol is glyceryl stearate.

[0119] According to preferred embodiments, at least one C12-C24 fatty acid ester of a C2-C24 polyol is present in the compositions of this disclosure in an amount (active material) of 0.1% to 2% by weight, and preferably 0.2% to 0.8% by weight, all weights being based on the total weight of the composition, including all intermediate ranges and sub-ranges.

[0120] Anionic carboxylic or carboxylate surfactants selected from fatty chain amino acids and their salts

[0121] According to this disclosure, emulsion compositions comprising at least one anionic carboxylic or carboxylate surfactant selected from the group consisting of amino acids modified with at least one C8-C30 hydrocarbon chain, preferably a C8-C24 hydrocarbon chain, and their salts, are proposed. The term "hydrocarbon chain" refers to a linear or branched, saturated or unsaturated organic group consisting primarily of hydrogen and carbon atoms, in which one or more carbon atoms may be replaced by an oxygen or nitrogen atom. Examples of C8-C30 hydrocarbon chains include C8-C30 acyl radicals.

[0122] Examples of amino acids include, but are not limited to, alanine, arginine, aspartic acid, glutamic acid, glycine, isoleucine, leucine, lysine, phenylalanine, serine, tyrosine, valine and sarcosine.

[0123] More specifically, the following compounds may be cited: dipotassium capryloyl glutamate, dipotassium undecylenoyl glutamate, disodium capryloyl glutamate, disodium cocoyl glutamate, disodium lauroyl glutamate, disodium stearoyl glutamate, disodium undecylenoyl glutamate, potassium capryloyl glutamate, potassium cocoyl glutamate, potassium lauroyl glutamate, potassium myristoyl glutamate, potassium stearoyl glutamate, potassium undecylenoyl glutamate, sodium capryloyl glutamate, sodium cocoyl glutamate, sodium lauroyl glutamate, sodium myristoyl glutamate, sodium olivoyl glutamate, sodium palmitoyl glutamate, sodium stearoyl glutamate, sodium undecylenoyl glutamate, [3-methyl cocoyl alaninate, [3-alaninate] lauroyl, methyl lauroyl [3-alaninate], myristoyl [3-alaninate, potassium lauroyl methyl [3-alaninate, sodium cocoyl alaninate,cocoyl méthyl [3-alaninate de sodium et myristoyl méthyl [3-alaninate palmitoyl glycinate de sodium, lauroyl glycinate de sodium, cocoyl glycinate de sodium, myristoyl glycinate de sodium, lauroyl glycinate de potassium, cocoyl glycinate de potassium, lauroyl sarcosinate de potassium, cocoyl sarcosinate de potassium, cocoyl sarcosinate de sodium, lauroyl sarcosinate de sodium, myristoyl sarcosinate de sodium, oléoyl sarcosinate de sodium, palmitoyl sarcosinate de sodium, lauroyl sarcosinate d'ammonium, lauroyl aspartate de sodium, myristoyl aspartate de sodium, cocoyl aspartate de sodium, caproyl aspartate de sodium, lauroyl aspartate disodique, myristoyl aspartate disodique, cocoyl aspartate disodique, caproyl aspartate disodique, lauroyl aspartate de potassium, myristoyl aspartate de potassium, cocoyl aspartate de potassium, caproyl aspartate de potassium, lauroyl aspartate dipotassique, myristoyl aspartate dipotassique, cocoyl aspartate dipotassique, caproyl aspartate dipotassique,And , their mixtures.

[0124] According to preferred embodiments, at least one anionic carboxylic or carboxylate surfactant is selected from compounds having the following structure:

[0125] [Chem.2] O ,(CH> ^COOM z^ XY

[0126] in which: • Z represents a saturated or unsaturated, linear or branched hydrocarbon-based group comprising 8 to 24 carbon atoms, preferably 8 to 22 carbon atoms, • X is a hydrogen atom or a methyl group; • n is equal to 0 or 1; • Y is a group chosen from a hydrogen atom and a group -CH3, -CH(CH3)2, -CH2CH(CH3)2, -CH(CH3)CH2CH3, -ch2c6h5, -ch2c2h4oh, -ch2 OH, -CH(OH)CH3, -(CH2)4NH2, -(CH2)3NHC(NH)NH2, -CH2C(O)OM+, -(CH2)2C(O)OH, and -(CH2)2C(O)OM+; and • M is a hydrogen atom or a cation such as sodium, potassium, ammonium, or triethanolamine.

[0127] According to preferred embodiments, in formula 2: • Z represents a linear or branched C8-C22 alkyl or alkenyl group; • X is a hydrogen atom or a methyl radical; • n is equal to 0; • Y is a hydrogen atom, a -(CH2)2C(O)OH group, or a -(CH2)2C(O)O-M+ group; and • M is a cation such as sodium, potassium, ammonium, or triethanolamine.

[0128] According to preferred embodiments, the composition according to this disclosure comprises at least one acyl glutamic acid (INCI name: acyl glutamic acid) or one of its salts (acyl glutamates). Preferably, the acyl glutamic acid(s) is / are selected from acyl glutamic acids in which the acyl group comprises from 8 to 30 carbon atoms, preferably from 10 to 24 carbon atoms, and preferably from 12 to 22 carbon atoms, such as, for example, lauroyl- glutamic acid, myristoylglutamic acid, palmitoylglutamic acid, stearylglutamic acid, behenoylglutamic acid, olivoyylglutamic acid, co-coylglutamic acid, and salts of these acids, in particular salts of alkali metals such as Na, Li or K, preferably Na or K, salts of alkaline earth metals such as Mg, or ammonium salts of said acids.

[0129] Examples of amino acid salts modified with at least one C8-C30 hydrocarbon chain include, but are not limited to, glutamate salts, and in particular dipotassium capryloyl glutamate, dipotassium undecylenoyl glutamate, disodium capryloyl glutamate, disodium cocoyl glutamate, disodium lauroyl glutamate, disodium stearoyl glutamate, disodium undecylenoyl glutamate, potassium capryloyl glutamate, potassium cocoyl glutamate, potassium lauroyl glutamate, potassium myristoyl glutamate, potassium stearoyl glutamate, potassium undecylenoyl glutamate, sodium capryloyl glutamate, sodium cocoyl glutamate, sodium lauroyl glutamate, and sodium myristoyl glutamate. sodium, sodium olivoyl glutamate, sodium palmitoyl glutamate, sodium stearoyl glutamate, sodium undecylenoyl glutamate.

[0130] Preferably, the acylglutamic acid(s) or one of their salts is / are selected from lauroylglutamic acid(s), cocoylglutamic acid(s), sodium stearoyl glutamate, potassium lauroyl glutamate, potassium cocoyl glutamate, sodium olivoyl glutamate, and mixtures thereof. Preferably, the acylglutamic acid or one of its salts is sodium stearoyl glutamate (INCI name). Such compounds are sold under the name Amisoft by Ajinomoto, and in particular under the references Amisoft CA, Amisoft LA, Amisoft HS 11 PF, Amisoft MK-11, Amisoft LK-11, and Amisoft CK-11, or alternatively under the name Eumulgin SG by Cognis.

[0131] We can also mention triethanolamine cocoyl glutamate sold under the name Amisoft CT12 by Ajinomoto, and triethanolamine lauroyl glutamate sold under the name Acylglutamate LT-12 by Ajinomoto.

[0132] As salts of acyl glutamic acid, we can also mention sodium hydrogenated suifoyl glutamate, such as the product sold under the reference Acylglutamate HS 11 by Ajinomoto and disodium hydrogenated tallow glutamate, such as the product sold under the reference Acylglutamate HS-21 by Ajinomoto.

[0133] One can also mention commercial mixtures of surfactants comprising at least one derivative of glutamic acid or a salt of said derivative, for example the mixture of acyl glutamate salts such as Amisoft LS-22 sold by Ajinomoto.

[0134] According to preferred embodiments of this disclosure, the compositions of this disclosure include the monosodium salt of n-stearoyl-L-glutamic acid (INCI name: sodium stearoyl glutamate), such as the product sold by Ajinomoto under the reference Amisoft HS 11 PF.

[0135] According to preferred embodiments, at least one amino acid modified with at least one C8-C30 hydrocarbon-based chain, and / or its salts, is preferably present in the compositions of this disclosure in an amount of 0.01% to 5% by weight, preferably 0.01% to 2% by weight, preferably 0.05% to 1% by weight, preferably 0.1% to 0.8% by weight, and preferably 0.1% to 0.5% by weight, all weights being relative to the total weight of the composition, including all intermediate ranges and sub-ranges. C12-C24 saturated fatty alcohols

[0136] According to preferred embodiments, compositions optionally comprising at least one saturated fatty alcohol (C2-24) are proposed. Preferably, the at least one saturated fatty alcohol (C2-24) is linear and / or comprises 14 to 22 carbon atoms. Suitable examples include, but are not limited to, cetyl alcohol, stearyl alcohol, cetearyl alcohol, myristyl alcohol, lauryl alcohol, tridecyl alcohol, pentadecyl alcohol, hexadecyl alcohol, arachidyl alcohol, and / or behenyl alcohol, with cetyl alcohol, stearyl alcohol, and / or cetearyl alcohol being the most preferred.

[0137] Commercially available cetyl alcohol includes, but is not limited to, those sold under the names Ecorol® 16 / 98 F and Ecorol® 16 / 98 P by Ecogreen Oleo-chemicals, Tegoalkanol® 16 by Evonik Goldschmidt, Lanette® 16 by Cognis, Vegarol ® 1698 by WF, Alkonat® 1698 P by Oxiteno, Cetyl Alcohol 98% MIN by Emery Oleochemicals, Ginol® 16 (98%) by Godrej Industries, Nacol® 16-98 by Sasol, Kalcol® 6098 by Kao and Acilol® 16 by Aegis Chemical.

[0138] Commercially available stearyl alcohol includes, but is not limited to, those sold under the names Tegoalkanol® 18 by Evonik Goldschmidt, Ecorol® 18 / 98 F and Ecorol® 18 / 98 P by Ecogreen Oleochemicals, Lanette® 18 by Cognis, Kalcol® 8098 by Kao, Acilol® 18 by Aegis Chemical, Nacol® 18-98 by Sasol and NAA® 45 by Nihon Yushi.

[0139] Commercially available cetearyl alcohol includes, but is not limited to, those sold under the names Ecorol® 68 / 50 F and Ecorol® 68 / 50 P by Ecogreen Oleochemicals, Lanette® O OR and Lanette® O OR Flakes by Cognis, Alkonat® 1618 C50 P by Oxiteno, Nafol® 16-18 EN by Sasol, Alcohol Cetoestearilico 50 / 50 by Industria Quimica Del Centre, Conol® 30 CK by New Japan Chemical, Cetylstearyl Alcohol 50:50 by Evonik Goldschmidt, Kalcol® 6850 by Kao, Vegarol® 1618 (50:50) by WF and Ginol® 1618 50:50 OR by Godrej Industries.

[0140] Commercially available behenyl alcohol includes, but is not limited to, those sold under the name Lanette 22 by BASF.

[0141] Preferably, the compositions of this disclosure have an alpha-gel structure, that is to say, they have a lamellar phase, assumed to be due to the presence of of a surfactant and a C12-C24 saturated fatty alcohol.

[0142] Where appropriate, at least one C12-C24 saturated fatty alcohol is preferably present in the compositions of this disclosure in an amount of 0.1% to 5% by weight, preferably 0.2% to 3% by weight, and preferably 0.5% to 2% by weight, all weights being based on the total weight of the composition, including all intermediate ranges and sub-ranges. Waxes

[0143] According to preferred embodiments, the compositions of this disclosure further optionally include at least one wax. “Wax” means a deformable or undeformable lipophilic compound that is solid at room temperature (25 °C), with a reversible solid / liquid phase change, and has a melting point of 30 °C or higher, which may be up to 120 °C. In particular, waxes suitable for use in the disclosed compositions preferably have a melting point of 60 °C or higher, and preferably 70 °C or higher.

[0144] The term “lipophilic compound” means a compound having an acid number and a hydroxyl number of less than 150 mg KOH / g.

[0145] The melting point corresponds to the temperature of the most endothermic peak observed on the thermal analysis (DSC) as described in ISO 11357-3; 1999. The melting point of the wax can be measured using a differential scanning calorimeter (DSC), for example the calorimeter sold under the name MDSC 2920 by TA Instruments or the calorimeter sold under the name DSC Q100 by TA Instruments with the TA Universal Analysis software.

[0146] A measurement protocol is as follows:

[0147] A 5 mg sample of wax placed in a crucible is subjected to a first temperature ramp from -20 °C to 100 °C at a heating rate of 10 °C / minute. It is then cooled from 100 °C to -20 °C at a cooling rate of 10 °C / minute and finally subjected to a second temperature ramp from -20 °C to 100 °C at a heating rate of 5 °C / minute. During the second temperature ramp, the change in the difference in power absorbed by the empty crucible and by the crucible containing the wax sample is measured as a function of temperature. The melting point of the compound is the temperature value corresponding to the peak of the curve representing the change in the difference in power absorbed as a function of temperature.

[0148] Waxes may be hydrocarbon waxes, silicone waxes and / or fluoro waxes, and may be of vegetable, animal, mineral and / or synthetic origin.

[0149] Preferably, where applicable, the wax(s) is / are present in the composition in a content ranging from 0.01% to 5% by weight, preferably from 0.1% to 3% by weight, and preferably from 0.2% to 2% by weight, relative to the total weight of the composition. position, including all intermediate ranges and sub-ranges.

[0150] According to preferred embodiments, the composition according to this disclosure comprises at least one wax of vegetable origin.

[0151] According to preferred embodiments, the composition according to this disclosure comprises at least one jojoba ester wax. The jojoba ester wax may be an unsaturated form of jojoba esters, which may be fully hydrogenated jojoba ester having the formula below:

[0152] [Chem.3] ^-COO-CHz-R1

[0153] in which: • RI is a CH3-(CH2)y group, y is equal to 16, 18, 20 or 22.

[0154] Jojoba ester wax can be obtained by hydrogenating a jojoba wax ester (jojoba oil) by crossing out the formula below:

[0155] [Chem.4] <■ «Wy « CH CH - OS: ~ « C - O » (¾ * Œj « CH * CM * (0¾ * (¾

[0156] in which x and y are equal to 6, 8, 10 or 12.

[0157] Jojoba wax esters are composed of straight-chain monounsaturated fatty alcohols and monounsaturated fatty acids. The only double bond is located in the middle (position n-9), starting from the final methyl group (-CH3) of the chain of the respective fatty acid or alcohol.

[0158] Such wax esters are composed of fatty alcohols and fatty esters having an even number of carbon atoms, primarily 20 and 22 carbon atoms. The resulting material comprises esters having chain lengths of 38, 40, 42, and 44 carbon atoms, with a small amount of 36- and 46-carbon esters present. The typical composition of the wax esters is shown below.

[0159] [Tables 1] Wax esters (X, Y) Typical chain length % (area per GPC) (6, 6) 36 1 (6, 8) (8, 6) 38 8 (6, 10) (8, 8) (10, 6) 40 39 (10, 8) (8, 10) 42 38 (10, 10) 44 13 (12, 10) (10, 12) 46 1

[0160] Jojoba wax ester can be derived from the seeds of the jojoba plant (Simmondsia chinensis).

[0161] Examples of jojoba wax ester include the product sold under the name Floraesters® 70 by International Flora Technologies Ltd, and the product sold under the name Jojoba Esters-70 by Vantage.

[0162] Preferably, where appropriate, jojoba ester wax is present in the composition in an amount ranging from 0.1% to 2% by weight, and preferably from 0.2% to 0.8% by weight relative to the total weight of the composition, including all intermediate ranges and sub-ranges.

[0163] According to preferred embodiments, the composition according to this disclosure comprises at least one additional hydrocarbon-based wax in addition to the jojoba ester mentioned above. Appropriate examples include, but are not limited to, beeswax, lanolin wax or Chinese insect wax, rice wax, camauba wax, candelilla wax, ouricury wax, esparto grass wax, cork fiber wax, sugar cane wax, Japanese wax, berry wax, shellac wax and sumac wax, Helianthus annuus (sunflower) seed wax; montan wax, microcrystalline waxes, paraffins and ozokerite; In particular, polyethylene waxes, polymethylene waxes, waxes obtained by Fisher-Tropsch synthesis and waxy copolymers, as well as their esters, can be used.Examples include beeswax, for example the product sold under the name White beeswax BR G889 by Koster Keunen, camauba wax, for example sold under the name Cerauba Tl Bio by Baerlocher, helianthus annuus (sunflower) wax sold under the name Sunflower Wax by Koster Keunen, or a mixture thereof. Preferably, the compositions in this disclosure include helianthus annuus (sunflower) seed wax.

[0164] Where appropriate, the additional hydrocarbon-based wax is preferably present in the composition in an amount ranging from 0.05% to 5% by weight, preferably from 0.1% to 1% by weight, and preferably from 0.1% to 0.5% by weight, relative to the total weight of the composition, including all intermediate ranges and sub-ranges.

[0165] According to preferred embodiments, the composition according to this disclosure comprises a mixture of glyceryl stearate, sodium steroyl glutamate, cetearyl alcohol, jojoba esters and sunflower seed wax, bearing the INCI name Cetearyl Alcohol (and) Jojoba Esters (and) Glyceryl Stearate (and) Sodium Stearoyl Glutamate (and) Helianthus Annuus Seed Cera (and) Polyglycerin-3, sold under the name Emulium® Dolcea MB by Gattefosse.

[0166] According to preferred embodiments, the composition according to the present invention comprises: • bemotrizinol; • at least one lipophilic acrylic polymer as defined above; • at least one C12-C24 saturated fatty alcohol; • at least one C12-C24 fatty acid ester of glycerol; • at least one anionic carboxylic or carboxylate surfactant chosen from Amino acids modified with at least one C8-C24 hydrocarbon chain, and their salts; and • at least one wax.

[0167] According to preferred embodiments, the composition according to the present invention comprises: • bemotrizinol; • at least one lipophilic acrylic polymer as defined above; • at least one C12-C24 saturated fatty alcohol; • at least one C12-C24 fatty acid ester of glycerol; • at least one anionic carboxylic or carboxylate surfactant chosen from Amino acids modified with at least one C8-C24 hydrocarbon chain, and their salts; and • at least one jojoba ester wax.

[0168] According to preferred embodiments, the composition according to the present invention comprises: • bemotrizinol; • at least one lipophilic acrylic polymer as defined above; • at least one C12-C24 saturated fatty alcohol; • at least one C12-C24 fatty acid ester of glycerol; • at least one acyl glutamic acid (INCI name: acyl glutamic acid) or one of its salts (acyl glutamates), the acyl group being a C10-C30 acyl group, preferably in C12-C22; • at least one jojoba ester wax.

[0169] According to preferred embodiments, the composition according to the present invention comprises: • bemotrizinol; • at least one lipophilic acrylic polymer as defined above; • at least one C12-C24 saturated fatty alcohol; • at least one C12-C24 fatty acid ester of glycerol; • at least one anionic carboxylic or carboxylate surfactant chosen from Amino acids modified with at least one C8-C24 hydrocarbon-based chain and their salts; • at least one jojoba ester wax; and • at least one Helianthus annuus (sunflower) seed wax.

[0170] According to preferred embodiments, the composition according to the present invention comprises: • bemotrizinol; • at least one lipophilic acrylic polymer as defined above; • at least one C12-C24 saturated fatty alcohol; • at least one C12-C24 fatty acid ester of glycerol; • at least one acyl glutamic acid (INCI name: acyl glutamic acid) or one of its salts (acyl glutamates), the acyl group being a C10-C30 acyl group, preferably C12-C22; • at least one jojoba ester wax; and • at least one Helianthus annuus (sunflower) seed wax.

[0171] According to preferred embodiments, the composition according to this disclosure is a fluid composition for skin care, in the form of an oil-in-water emulsion, comprising, relative to the total weight of the composition: i. bemotrizinol; ii. from 0.05% to 10% by weight of a lipophilic acrylic polymer comprising monomer units of formulas (A) and (B):

[0172] [Chem.l]

[0173] in which: • RI, independently in each case, is chosen from among the alkyl or alkenyl radicals, and

[0174] at least 60% by weight of the RI groups are radicals selected from stearyl and behenyl radicals, the percentage by weight referring to the sum of all the RI groups present in the polymer, and

[0175] the weight ratio between the sum of all hydroxyethyl acrylate motifs and the sum of all acrylate motifs bearing the RI group ranges from 1:30 to 1:1,

[0176] and the sum of the total of motifs A and B is at least 95% by weight relative to the total weight of the polymer; i. from 0.2% by weight to 0.8% by weight of at least one jojoba ester wax of formula 3:

[0177] [Chem.3] ^-COO-CHz-R1

[0178] where RI is CH3-(CH2)y-, y is 16, 18, 20 or 22; i. from 0.5% by weight to 2% by weight of at least one C12-C24 saturated fatty alcohol chosen from cetyl alcohol, stearyl alcohol and cetearyl alcohol; ii. from 0.2% by weight to 0.8% by weight of at least one C12-C24 fatty acid ester of glycerol selected from glyceryl laurate, glyceryl oleate, glyceryl stearate, glyceryl palmitate and mixtures thereof; and iii. 0.1% by weight to 0.5% by weight of at least one surfactant chosen from among acyl glutamic acids (INCI name: acyl glutamic acid) and their salts (acyl glutamates), the acyl group being a C10-C30 acyl group, preferably C12-C22; even more preferably, it is the stearoyl radical. Oil

[0179] According to preferred embodiments of this disclosure, compositions further comprising at least one oil are proposed. “Oil” means a substance that is hydrophobic and lipophilic, and that is a liquid at approximately room temperature (20 to 25 °C) and at approximately atmospheric pressure (760 mm Hg).

[0180] Suitable oils include volatile and / or non-volatile oils. These oils may be any acceptable oil, including, but not limited to, silicone oils and / or hydrocarbon oils.

[0181] According to certain embodiments, the compositions of this disclosure preferably comprise one or more volatile silicone oils. Examples of such volatile silicone oils include linear or cyclic silicone oils. These silicones, containing 2 to 7 silicon atoms, are optionally substituted with alkyl or alkoxy groups of 1 to 10 carbon atoms. Specific oils that may be used in disclosure include octamethyltetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, heptamethyloctyltrisiloxane, hexamethyldisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane, and mixtures thereof. Other volatile oils that may be used include KF 96A with a viscosity of 6 cSt, a commercial product from Shin Etsu with a flash point of 94 °C. Preferably, volatile silicone oils have a flash point of at least 40 °C.

[0182] Non-limiting examples of volatile silicone oils are listed in Table 2 below.

[0183] [Tables2] Compound Flash Point (°C) Viscosity (cSt) Octyltrimethicone 93 1.2 Hexyltrimethicone 79 1.2 Decamethylcyclopentasiloxane 72 4.2 (cyclopentasiloxane or D5) 55 2.5 Octamethylcyclotetrasiloxane 93 7 (cyclotetramethylsiloxane or D4) 63 1.7 Dodecamethylcyclohexasiloxane (D6) 94 6 Decamethyltetrasiloxane (L4) 56 1.5 KF-96 A from Shin Etsu PDMS (polydimethylsiloxane) DC 200 (1.5 cSt) from Dow Corning PDMS DC 200 (2 cSt) from Dow Corning 87 2

[0184] In addition, a linear volatile silicone oil may be used in this disclosure. Suitable linear volatile silicone oils include those described in US Patent No. 6,338,839 and in WO03 / 042221, the contents of which are incorporated herein by reference. In one embodiment, the linear volatile silicone oil is decamethyltetrasiloxane. In another embodiment, decamethyltetrasiloxane is further combined with another solvent that is more volatile than decamethyltetrasiloxane.

[0185] According to certain embodiments of this disclosure, the composition preferably comprises one or more non-silicone volatile oils and may be selected from volatile hydrocarbon oils, volatile esters, and volatile ethers. Examples of such volatile non-silicone oils include, but are not limited to, The product is limited to volatile hydrocarbon oils with 8 to 16 carbon atoms and mixtures thereof, and in particular, branched C8 to C16 alkanes such as C8 to C16 isoalkanes (also known as isoparaffins), isohexadecane, isododecane, isodecane, and, for example, oils sold under the brand names Isopar or Permethyl. Preferably, non-silicone volatile oils have a flash point of at least 40 °C.

[0186] Non-limiting examples of volatile non-silicone oils are given in Table 3 below.

[0187] [Tables3] Compound Flash Point (°C) Isododecane 43 Propylene glycol n-butyl ether 60 Ethyl 3-Ethoxypropionate 58 Propylene glycol methyl ether acetate 46 Isopar L (Cn-Ci3 isoparaffin) 62 Isopar H (Cn-Ci2 isoparaffin) 56

[0188] According to certain embodiments of this disclosure, the composition includes at least one non-volatile oil. Examples of non-volatile oils that may be used in this disclosure include, but are not limited to, polar oils such as, for example: • esters and ethers, in particular fatty acids, such as oils of formula R1COOR2, in which RI represents the remainder of a fatty acid having from 8 to 29 carbon atoms, and R2 represents a hydrocarbon chain, branched or unbranched, containing from 3 to 30 carbon atoms, such as for example Purcellin oil, isononyl isononanoate, isopropyl myristate, ethyl-2-hexyl palmitate, octyl-2-dodecyl stearate, octyl-2-dodecyl erucate, isostearyl isostearate; hydroxylated esters such as isostearyl lactate, octylhydroxy stearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate, heptanoates, octanoates, fatty alcohol decanoates; polyol esters, such as propylene glycol dioctanoate, neopentyl glycol diheptanoate and diethylene glycol diisononanoate;triglycerides such as caprylic / capric acid triglycerides, for example, those sold by Stearineries Dubois or those sold under the names Miglyol 810, 812 and 818 by Dynamit Nobel; and pentaerythritol esters such as pentaerythrityl tetraisostearate or dipentaerythrityl pentaisononanoate; • ethers containing 10 to 40 carbon atoms; • liquid C8 to C26 fatty alcohols, for example oleyl alcohol, cetyl alcohol, stearyl alcohol and cetearyl alcohol; • hydrocarbon oils of animal origin, such as perhydrosqualene; • vegetable-derived hydrocarbon oils, such as triglycerides fatty acid liquids having 4 to 10 carbon atoms such as heptanoic or octanoic acid triglycerides or, for example, sunflower, corn, soybean, pumpkin, grapeseed, sesame, hazelnut, apricot, macadamia, ara, sunflower, castor, avocado oils, caprylic / capric acid triglycerides such as those marketed by Stearineries Dubois or those marketed under the names Miglyol 810, 812 and 818 by Dynamit Nobel, coco-caprylate / caprate (esterified coconut oil), jojoba oil, shea butter oil; and • their mixtures.

[0189] In addition, examples of non-volatile oils that may be used in this disclosure include, but are not limited to, non-polar oils such as branched and unbranched hydrocarbons, in particular Vaseline (petrolatum), paraffin oil, squalane, squalene, hydrogenated polyisobutene, hydrogenated poly-lydecene, polybutene, a mineral oil, pentahydrosqualene, and mixtures thereof.

[0190] According to certain embodiments of this disclosure, the compositions of this disclosure include at least one nonvolatile silicone oil. Appropriate examples of such silicone oils include, but are not limited to, nonvolatile silicone fluids such as, for example, polyalkyl (aryl) siloxanes. Appropriate polyalkyl siloxanes include, but are not limited to, polydimethyl siloxanes, which are designated CTFA dimethicone, polydiethyl siloxane, phenyl trimethicone, trimethyl pentaphenyl trisiloxane, phenyldimethicone, phenyltrimethylsi-loxydiphenylsiloxane, diphenyldimethicone, and diphenylmethyldiphenyltrisiloxane, and the siloxanes disclosed in the U.S. patent application publication No. 2004 / 0126350, the full disclosure of which is incorporated herein by reference. Specific examples of suitable high-viscosity silicone oils include, but are not limited to, PCR 15 M 30 (500 cSt) or Wacker Belsil PDM 1000 (1000 cSt) and Dow Corning 200 (350 cSt) (values ​​in parentheses represent viscosities at 25 °C).

[0191] Particularly preferred oils include, but are not limited to, one or more of the following: diisopropyl sebacate, C12-15 alkyl benzoate, phenethyl benzoate, isopropyl lauroyl sarcosinate, diisopropyl adipate, dibutyl adipate, dicaprylyl carbonate, dicaprylate / dicaprate, coco glycerides, caprylic / capric triglyceride, isopropyl myristate, isopropyl palmitate, coco caprylate / caprate, ethylhexyl palmitate, isononyl isononanoate, octyl dodecanol, isohexadecane, isododecane, dicaprylyl ether, C15-19 alkane, and mixtures thereof.

[0192] According to preferred embodiments, at least one oil is present in the compositions of this disclosure in an amount ranging from about 1% to about 50% by weight, more preferably from about 5% to about 40% by weight, and preferably from about 10% to about 35% by weight, relative to the total weight of the composition, including all intermediate ranges and sub-ranges such as, for example, 15% to 40%, 20% to 45%, etc. Aqueous Phase

[0193] According to this disclosure, compositions comprising an aqueous phase including water are proposed. Preferably, when the compositions of this disclosure contain water, they are in the form of an emulsion containing an external aqueous phase such as an oil-in-water (O / W) emulsion or a water-in-oil-in-water (W / O / W) emulsion. Preferably, when in the form of an emulsion, the oily phase may contain silicone oils (for example, Si / W or W / Si emulsion) or hydrocarbon oils. Where applicable, the water is preferably present in an amount of approximately 10% to approximately 80% by weight, preferably approximately 20% to approximately 70% by weight, preferably approximately 35% to approximately 65% ​​by weight, including all intermediate ranges and sub-ranges, all weights being based on the total weight of the composition.

[0194] The aqueous phase may optionally further comprise at least one water-soluble organic solvent that is liquid at room temperature and atmospheric pressure. For example, such at least one water-soluble organic solvent may include: • triethyl citrate; • C1-C5 monoalcohols having a C1-C5 alkane chain and a single hydroxyl (OH) group. Suitable C1-C5 monoalcohols include methanol, ethanol, propanol, isopropanol, butanol, and mixtures thereof; • polyols (compounds having 2 or more hydroxyl groups) having, for example, from 2 to 20 carbon atoms, preferably from 2 to 6 carbon atoms, such as, for example, glycerol, diglycerol, propylene glycol, isoprene glycol, dipropylene glycol, butylene glycol, hexylene glycol, 1,3-propanediol, pentylene glycol, simple sugars and water-soluble polyalkylene glycols; • and their mixtures.

[0195] According to preferred embodiments, at least one water-soluble organic solvent is chosen from the group consisting of ethanol, dipropylene glycol, butylene glycol, propanediol and propylene glycol and their mixtures.

[0196] Where applicable, the water-soluble organic solvent(s) is / are preferably present in the compositions of this disclosure in an amount ranging from about 0.5 to about 40% by weight, preferably from about 3 to about 30% by weight, and preferably from about 5 to about 20% by weight relative to the total weight of the composition, including all intermediate ranges and sub-ranges such as, for example, 2% to 15%, 2% to 25%, 7.5% to 30%, etc. Additional optional ingredients

[0197] The compositions of this disclosure may also optionally include at least one additional additive or auxiliary commonly used in cosmetic compositions and known to a person skilled in the art as being capable of being incorporated into such compositions. Such additives or auxiliaries may be selected from additional film-forming agents, additional surfactants, coloring agents (e.g., dyes and colorants), waxes, thixotropic agents (e.g., clays), fillers, preservatives, perfumes, antioxidants, free radical scavengers, spreading agents, dispersing agents, antifoaming agents, neutralizing agents, stabilizing agents, active ingredients selected from essential oils, moisturizing agents, vitamins, actives, proteins, ceramides, plant extracts, fibers and the like, wetting agents and mixtures thereof.However, preferably, the compositions in this disclosure are "free", "substantially free" or "devoid" of such additives.

[0198] A person skilled in the art shall ensure that the optional additional additives are chosen and / or their quantity so that the advantageous properties of the composition as disclosed are not, or are not substantially, compromised by the envisaged addition.

[0199] It goes without saying that the composition of the disclosure must be cosmetically or dermatologically acceptable, that is, it must contain a physiologically acceptable, non-toxic carrier. The composition may be in any pharmaceutical form normally used in the cosmetic and dermatological fields that is suitable for topical administration as mentioned above.

[0200] These auxiliary additives may be present in the composition in a proportion of 0% to 99% (such as 0.01% to 90%) relative to the total weight of the composition and furthermore such as 0.1% to 50% by weight (where appropriate), including all intermediate ranges and sub-ranges.

[0201] In accordance with this disclosure, the compositions in this disclosure may be a standalone product (for use alone), or they may be a product for use in conjunction with another composition, for example, a base coat composition (makeup base), a color coat composition, or a top coat composition (overcoat). It should be understood When compositions of this disclosure are applied to keratinous materials in the form of any of these compositions, such application may comprise one or more layers of the product. Thus, for example, the application of at least one color layer composition may comprise one or more color layers; the application of at least one topcoat composition may comprise one or more topcoats; the application of at least one basecoat composition may comprise one or more basecoats. Preferably, such basecoat, color layer, and topcoat compositions contain three or fewer layers of compositions, preferably two or fewer layers of compositions, and preferably only one layer of compositions.

[0202] During the application of compositions of this disclosure, the base coat (if any) is typically applied directly to the keratinous material, the color coat is typically applied either directly to the keratinous material (if no base coat is present) or to a previously applied base coat, and the top coat (if any) is typically applied to a color coat.

[0203] According to preferred embodiments of this disclosure, methods for treating, protecting, improving the appearance, caring for and / or making up keratinous materials by applying compositions of this disclosure to the keratinous material in a quantity sufficient to treat the keratinous material, improve its appearance, care for it and / or make it up, are proposed.

[0204] Preferably, the "makeup" of the keratinous material includes the application of a composition comprising at least one coloring agent to the keratinous material in sufficient quantity to provide color and / or an optical effect to the keratinous material.

[0205] Preferably, the "protection" of the keratinous material includes the application of a composition of this disclosure to protect the keratinous material from damage resulting from exposure to UV rays.

[0206] In accordance with previous embodiments, the compositions of this disclosure are applied topically to the keratinous material in a sufficient quantity to treat, improve the appearance of, care for, and / or conceal the keratinous material. The compositions can be applied to the desired area as needed, preferably once or twice daily, more preferably once daily, and then preferably allowed to dry before being subjected to contact such as with clothing or other objects (e.g., clothing or a top coat). Preferably, the composition is allowed to dry for approximately 1 minute or less, more preferably for approximately 45 seconds or less.

[0207] According to preferred embodiments of this disclosure, methods for manufacturing emulsion compositions comprising the combination of bis-ethylhexyloxyphenol methoxyphenyl triazine, at least one lipophilic acrylic polymer, at least one C2-C24 fatty acid ester of a C2-C24 polyol, and at least one carboxylic anionic surfactant or carboxylate selected from the group consisting of amino acids modified with at least one C8-C30 hydrocarbon-based chain and their salts, during the formation of the emulsion compositions are proposed.

[0208] This disclosure also considers pre-packaged kits and / or materials suitable for consumer use containing one or more compositions as described herein, alone or in combination with other consumer care products such as makeup products like primers, top coats, removal compositions, etc. The packaging and application device for any subject of this disclosure may be selected and manufactured by persons skilled in the art based on their general knowledge and adapted according to the nature of the composition to be packaged. Indeed, the type of device to be used may be particularly related to the consistency of the composition, especially its viscosity; it may also depend on the nature of the constituents present in the composition, such as the presence of volatile compounds.

[0209] Unless otherwise stated, all numbers expressing quantities of ingredients, reaction conditions, etc., used in the patent specification and claims are to be understood as modified in all cases by the term "approximately". Accordingly, unless otherwise stated, the numerical parameters presented in the following patent specification and the attached claims are approximations that may vary depending on the desired properties that are sought to be obtained through this disclosure.

[0210] Although the numerical ranges and parameters defining the general scope of disclosure are approximations, the numerical values ​​given in the specific examples are reported as accurately as possible. However, every numerical value inherently contains some errors necessarily resulting from the standard deviation found in its respective measurements. The following examples are intended to illustrate disclosure without, however, limiting its scope. Percentages are given on a weighted basis.

[0211] Example 1 - Tinosorb S Fresh Liquid Serum SPF 50 US Ingredient Concentration % WATER / AQUA QS CHELATING AGENT 0.3 PRESERVATIVE 1 POLYOL 10 WAXES / FATTY ALCOHOL / SURSACIACTIVE 2.5 STARCH 0.5 SCLEROTIC GUM 0.5 BUTYL METHOXYDIBENZOYLMETHANE 3 HOMOSALATE / OCTISALATE 14 BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE 5 C12-22 COPOLYMER ALKYL ACRYLATE / HYDROXYETHYLACRYLATE 1.5 C15-19 ALKANE 5 ACTIVE AGENT 1

[0213] Exemple 2 - Sérum liquide frais SPF 50 US Tinosorb S (avec renforçateur) INCI (US / UE) Concentration % WATER / AQUA QS CHELATING AGENT 0,3 PRESERVATIVE 1 POLYOL 10 WAXES / FATTY ALCOHOL / SURFACTANT 2,5 STARCH 0,5 SCLEROTIUM GUM 0,5 ETHYLHEXYL SALICYLATE 5 BUTYL METHOXYDIBENZOYLMETHANE 3 HOMOSALATE / OCTISALATE 14 ETHYLHEXYL METHOXYCRYLENE 2 BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE 5 C12-22 ALKYL ACRYLATE / HY- DROXYETHYLACRYLATE COPOLYMER 1,5 C15-19 ALKANE 5 ACTIVE AGENT 1

Claims

Demands

1. Emulsion composition comprising bemotrizinol, at least one lipophilic acrylic polymer, at least one C2-C24 fatty acid ester of a C2-C24 polyol, and at least one carboxylic anionic surfactant or carboxylate selected from the group consisting of amino acids modified with at least one C8-C30 hydrocarbon-based chain and their salts, wherein the at least one lipophilic acrylic polymer comprises monomeric motifs of formulas (A) and (B): in which: RI, independently in each case, is chosen from among the alkyl and alkenyl radicals, and at least 60% by weight of the RI groups are radicals selected from stearyl and behenyl radicals, the weight percentage referring to the sum of all RI groups present in the polymer, and the weight ratio between the sum of all hydroxyethyl acrylate motifs and the sum of all acrylate motifs bearing the Ri group ranges from 1:30 to 1:1; and the sum of the total weight of motifs A and B is at least 95% by weight relative to the total weight of the polymer, the polymer having a number-average molecular weight (Mn) ranging from 2000 to 9000 g / mol; and in which the composition has one or more of the following properties: a critical wavelength of at least 370 nm; an FPUVA / FPS ratio of at least 1 / 3 and a UVA1 / UV ratio of 0.7 or more.

2. Composition according to claim 1, wherein the composition has two or more of the properties, preferably all three properties.

3. Composition according to any one of the preceding claims, wherein the composition also has an FPS value of at least 30.

4. Composition according to any one of the preceding claims, wherein at least one lipophilic acrylic polymer comprises at least 70% by weight of RI groups that are behenyl and / or stearyl radicals, preferably at least 80% by weight, and preferably at least 90% by weight relative to the total weight of the polymer.

5. Composition according to any one of the preceding claims, wherein at least one lipophilic acrylic polymer comprises all the RI groups of the stearyl and / or behenyl radicals.

6. Composition according to any one of the preceding claims, wherein the pH is 6 or higher.

7. Composition according to any one of the preceding claims, wherein the composition is free from mineral UV filters, oxybenzone and / or octinoxate.

8. Composition according to any one of the preceding claims, wherein the composition comprises 10% by weight or less relative to the total weight of the composition of additional organic UV filters.

9. Composition according to any one of the preceding claims, further comprising at least one coloring agent.

10. Composition according to any one of the preceding claims, further comprising at least one active agent.